Browse Tag

Stocks

Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

Current Stock Price & Recent Performance (Nov 5, 2025) As of November 5, 2025, Teradata’s stock trades in the mid-$20s after a sharp post-earnings rally. The latest trade was around $24.64, up ~19% in a single session reuters.com. This big jump followed the company’s Q3 earnings announcement and reflects renewed investor confidence. Prior to the earnings, TDC was hovering near $20, meaning the stock has swiftly regained lost ground. This surge also carries technical significance. On Nov 5, Teradata broke above its 200-day moving average (~$22.72), hitting intraday highs around $26.39 news.technicalanalysischannel.com. Crossing above the 200-day average is seen as
SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

Stock Price & Recent Performance (Nov 2025) SoFi Technologies’ stock has been on a tear in 2025, dramatically outperforming the broader market. As of November 5, 2025, SOFI trades around $29–30 per share, not far from its all-time high set just days earlier tradingview.com. In late October, the stock spiked to an intraday record of $32.57 (an all-time high) 247wallst.com, buoyed by optimism around its earnings. Even after pulling back about 7% from the peak in early November 247wallst.com, SoFi shares are still up roughly 91% year-to-date and +171% versus a year ago tradingview.com – a meteoric rise that has
5 November 2025
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Company Background and Business Model Palantir Technologies is a pioneering data analytics and software company founded in 2003 by Peter Thiel, CEO Alex Karp, and others. Originally known for its work with U.S. intelligence agencies, Palantir built its reputation developing “big data” platforms for defense and national security. Its flagship Gotham platform is widely used by government and military clients to synthesize intelligence data, while its Foundry platform serves commercial enterprises in industries from finance to healthcare. In 2023, Palantir launched its new Artificial Intelligence Platform (AIP) to bring the power of large language models and AI agents into these
Roche’s $3.5B Bet on 89bio (ETNB) – Stock Soars to New Highs as NASH Breakthrough Looms

Roche’s $3.5B Bet on 89bio (ETNB) – Stock Soars to New Highs as NASH Breakthrough Looms

Recent Developments and News (Nov 2025) 89bio has dominated biotech headlines in late 2025 due to Roche’s takeover move. On October 30, 2025, Roche announced it had successfully completed a tender offer for 89bio at $14.50/share + a $6.00 CVR, and would immediately merge 89bio into its subsidiary roche.com investing.com. By acquiring over 60% of shares in the tender (and securing another ~27% via guaranteed delivery), Roche was able to execute a short-form merger without a shareholder vote investing.com investing.com. All remaining ETNB shares will convert into the same $14.50 + CVR deal, and 89bio’s stock will cease trading on Nasdaq investing.com
5 November 2025
Nuvve Holding Corp’s Stock Skyrockets 50% – Can This EV Grid Pioneer Overcome the Odds?

Nuvve Holding Corp’s Stock Skyrockets 50% – Can This EV Grid Pioneer Overcome the Odds?

Latest News & Press Releases In the first week of November 2025, Nuvve made headlines with a mix of hopeful and cautionary news. On October 28, the company received a reprieve from Nasdaq – a hearings panel granted Nuvve until December 31, 2025 to cure its listing deficiencies, after the stock traded below $1 for over 30 days and the firm’s equity fell short of requirements stocktitan.net stocktitan.net. This extension (announced via an 8-K filing on Oct 31) staves off an immediate delisting, but it comes with conditions and no guarantee of success stocktitan.net. Management emphasized it will pursue its
Hertz Stock Skyrockets on Surprise Profit – Inside HTZ’s 2025 Comeback Rally

Hertz Stock Skyrockets on Surprise Profit – Inside HTZ’s 2025 Comeback Rally

Recent Stock Performance & Surge After Earnings Hertz stock has been on a rollercoaster in 2025. After starting the year in the low-to-mid single digits, HTZ shares languished under short-seller pressure until a sharp reversal this fall. Year-to-date, the stock has climbed ~84% stocktwits.com, dramatically outperforming the broader market, and is up about 142% from a year ago finviz.com. The rally accelerated in early November when Hertz’s Q3 earnings blew past expectations and confirmed a return to profitability. On November 4, 2025, Hertz announced a surprise profit, sending the stock up 36.2% in a single day to $6.73 stocktwits.com. This
5 November 2025
Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Financial Health and Earnings Trends Teva’s financial turnaround appears to be gaining steam, driven by both top-line growth and disciplined cost management. Quarterly revenue has now grown year-over-year for 11 straight quarters investing.com, marking a sustained rebound after a difficult past decade. In Q3 2025, revenue rose ~3% YoY (1% in constant currency) to $4.48 B investing.com, while adjusted earnings jumped to $0.78 per share (from $0.69 a year ago) reuters.com. Notably, this beat Wall Street estimates by ~$0.10 and marked Teva’s strongest earnings surprise of 2025 reuters.com. The growth engines are Teva’s newer branded drugs: movement-disorder treatment Austedo, migraine injection
Lemonade (LMND) Stock Soars on Q3 Beat – Is Insurtech Growth Sustainable?

Lemonade (LMND) Stock Soars on Q3 Beat – Is Insurtech Growth Sustainable?

Recent News: Q3 Results and Market Reaction On Nov. 5, 2025 after market-close, Lemonade released its Q3 financials, and the stock surged. Both press coverage and company statements highlighted robust top-line growth and improving loss metrics. For example, Investing.com reported revenue +42% YOY to $194.5M (well above the ~$184–185M expected) and a narrower-than-forecast loss of $0.51 per share au.investing.com. It noted in-force premium (IFP) up 30% YOY to $1.16B – an eighth consecutive quarter of accelerating growth au.investing.com. The CEO, Daniel Schreiber, said: “In Q3, we continued both our growth acceleration — crossing 30% IFP growth ahead of schedule — and
Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Stocks Plunge on AI Bubble Fears as Wall Street Warns of a 20% Correction

Rally Meets Reality: Tech Stocks Finally Cool Off After a year of spectacular gains, stocks have abruptly stumbled, raising the question of whether the market got ahead of itself. The S&P 500 and Nasdaq Composite just suffered their biggest one-day percentage drops since early October channelnewsasia.com, a sign that the gravity-defying surge in tech shares is meeting some pushback. On Tuesday (Nov. 4), the Nasdaq sank over 2% while the S&P 500 fell around 1.2%, and the Dow – which is less tech-centric – dipped 0.5% channelnewsasia.com. What triggered the abrupt shift in sentiment? Valuations. Investors are increasingly nervous that
Luxury Boom vs. Fed Gloom: European Markets Whipsaw (Sept 23–24, 2025)

5 Stocks You Need to Buy Now (November 4, 2025) – Tech, Energy, Biotech & More

Key Takeaways (November 4, 2025) <br> Table: Key Metrics for Top 5 Stocks (Nov 4, 2025) Company (Ticker) Price (Nov 4, 2025) Market Cap Trailing P/E Forward P/E Dividend Yield Amazon.com (AMZN) ~$254 morningstar.com $2.60 T macrotrends.net ~34× finance.yahoo.com ~29× finance.yahoo.com N/A (growth) JPMorgan Chase (JPM) ~$309 marketbeat.com $850 B marketbeat.com 15.3× marketbeat.com ~17× (est.) 1.9% marketbeat.com Eli Lilly (LLY) ~$863 investing.com $803 B stockanalysis.com 53.6× finance.yahoo.com 27.2× finance.yahoo.com ~0.7% macrotrends.net Exxon Mobil (XOM) ~$114 reuters.com $488 B macrotrends.net 15.8× finance.yahoo.com 15.0× finance.yahoo.com 3.6% marketbeat.com Alibaba Group (BABA) ~$168 finance.yahoo.com ~$375 B stockanalysis.com ~17× seekingalpha.com 9.8× nasdaq.com N/A (reinvesting) (Market caps in USD; P/E =
4 November 2025
Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)

7 Best Stocks to Buy Now for Big Gains (November 2025 Edition)

Key Takeaways Market Overview: Rally Rolls On, With Underlying Risks 2025 has been a banner year for stocks globally. In the U.S., the S&P 500 and Nasdaq have repeatedly notched all-time highs reuters.com, fueled by strong corporate earnings (especially in tech) and easing inflation amid a recent Federal Reserve rate cut markets.chroniclejournal.com. The Dow Jones Industrial Average is up ~12% year-to-date, the S&P 500 +16%, and the Nasdaq Composite +22% through the end of October markets.chroniclejournal.com. European markets have also surged – the Euro Stoxx 600 is up ~25% (in USD terms) this year core.axa-im.com – and Asian indices hit
Uranium Boom or Bust? Denison Mines (DNN) Stock Soars on Nuclear Revival – Full 2025 Analysis

Uranium Boom or Bust? Denison Mines (DNN) Stock Soars on Nuclear Revival – Full 2025 Analysis

Stock Forecast and Investment Outlook Denison Mines presents a high-upside, high-risk profile as an investment. Here we outline the bull case vs. bear case for DNN stock going forward: Bullish Case Bearish Case In conclusion, Denison Mines (DNN) offers a compelling story at the crossroads of a global nuclear energy revival. The company has an enviable asset – a high-grade uranium project with innovative mining technology that could come on-line just as the world’s uranium supply crunch hits. It boasts a solid balance sheet and has garnered positive attention from industry observers and analysts marketbeat.com. These factors underpin the optimistic
1 2 3 27
Go toTop